Tuberculosis drug development pipeline: Progress and hope

Melvin Spigelman; Stephen Gillespie

doi:10.1016/S0140-6736(06)68388-8

Tuberculosis drug development pipeline: Progress and hope

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	945-947
Number of pages	3
Journal	Lancet
Volume	367
Issue number	9514
DOIs	https://doi.org/10.1016/S0140-6736(06)68388-8
Publication status	Published - 18 Mar 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0140-6736(06)68388-8

Cite this

@article{825dbb08266e40059671ccfc21e68c28,

title = "Tuberculosis drug development pipeline: Progress and hope",

author = "Melvin Spigelman and Stephen Gillespie",

year = "2006",

month = mar,

day = "18",

doi = "10.1016/S0140-6736(06)68388-8",

language = "English",

volume = "367",

pages = "945--947",

journal = "Lancet",

issn = "0140-6736",

publisher = "University of California Press",

number = "9514",

}

TY - JOUR

T1 - Tuberculosis drug development pipeline

T2 - Progress and hope

AU - Spigelman, Melvin

AU - Gillespie, Stephen

PY - 2006/3/18

Y1 - 2006/3/18

UR - https://www.scopus.com/pages/publications/33645001016

U2 - 10.1016/S0140-6736(06)68388-8

DO - 10.1016/S0140-6736(06)68388-8

M3 - Review article

C2 - 16546546

AN - SCOPUS:33645001016

SN - 0140-6736

VL - 367

SP - 945

EP - 947

JO - Lancet

JF - Lancet

IS - 9514

ER -

Tuberculosis drug development pipeline: Progress and hope

UN SDGs

Access to Document

Other files and links

Cite this